Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

136.87 +3.43 (+2.57%)
Official Closing Price Updated: 7:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence
Your stock screening and research process will never be the same. 
Via The Motley Fool
AbbVie Unusual Options Activity
 
Via Benzinga
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
These two blue-chip dividend stocks offer investors a reliable income stream in a volatile market. 
Via The Motley Fool
Use These 3 Strategies to Make $1,000 in Passive Income Per Year
It's worth having these approaches in your investor toolkit. 
Via The Motley Fool
2 Reasons to Buy AbbVie, and 1 Reason to Sell
AbbVie shares rose in the double digits last year. 
Via The Motley Fool
AbbVie Provides Regulatory Update On Parkinson's Disease Drug Candidate
AbbVie Inc (NYSE: ABBV) provided a regulatory update on its New Drug Application (NDA) for  
Via Benzinga
Price Over Earnings Overview: AbbVie
 
Via Benzinga
This Is What Whales Are Betting On AbbVie
 
Via Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
 
Via Benzinga
Is It Too Late to Buy AbbVie Stock?
AbbVie stock and earnings have increased over time. 
Via The Motley Fool
These 3 Dividend Growers Yield More Than the 10-Year Note
Dividend aristocrats with yields greater than the 10-year note yield plus the potential for price appreciation could be a winning formula in this environment. 
Via MarketBeat
Topics Bonds
Exposures Debt Markets
4 Top Value Stock ETFs for Long-Term Wealth Building
It could be value's time to shine for the first time in years. 
Via The Motley Fool
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
It's still unclear whether CMS will include those drugs in its negotiation list. 
Via Investor's Business Daily
2 Growth Stocks to Buy Before the Bull Market Arrives
Long-term investors shouldn't hesitate to add these stocks to their portfolios. 
Via The Motley Fool
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
Under Joe Biden's signature Inflation Reduction Act, drugmakers for twenty-seven drugs will be penalized for charging prices that rise faster than inflation for people with disabilities or the elderly... 
Via Benzinga
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. 
Via MarketBeat
Oracle, AbbVie And This Gold Fund: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Oracle Corporation (NYSE: ORCL) as his pick. 
Via Benzinga
Dividend Income Update February 2023
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
5 Forever Dividend Stocks
These five dividend stocks make it a priority to return money to shareholders. 
Via The Motley Fool
Diversify Your Income with These 2 High-Yielding Dividend ETFs
Diversification is a term widely used when it comes to investing in the stock market. It means spreading your investment across different sectors and indust 
Via MarketBeat
Topics ETFs
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
 
Via Benzinga
3 No-Brainer Dividend Stocks to Buy in March
Going with these great dividend stocks is an easy choice. 
Via The Motley Fool
Reap Monthly Income With This Combination Of 3 Stocks
While the majority of stocks pay quarterly dividends, investors can still construct a portfolio that allows them to get paid monthly. 
Via Talk Markets
3 Surefire Stocks That Are Screaming Buys in March
High-growth industries are risky, but they also have tremendous potential. 
Via The Motley Fool
3 High-Yield Dividend Stocks to Buy Before the Next Bull Rally
Here's why you'll want to hurry up and buy these stocks before the next big market rally pushes them out of reach. 
Via The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
 
Via Benzinga
How to Pick the Best Dividend Stocks
A stock’s dividend yield is a key metric for investors, so what is a good dividend yield? We’ll explore the answer in this article. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
The Stock That Tripled in a Day...And May Not Be Done
Reata Pharmaceuticals now has a long-coveted commercialized drug in its portfolio. Should investors covet this biotech stock for their portfolios? 
Via MarketBeat
7 Dividend Kings to Buy for an Uncertain Market Environment
With so much turbulence in the global economy, these dividend kings to buy may help you weather the extreme storm. 
Via InvestorPlace
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
Over the past week, the market had a nice uptick making it harder for defensive sectors like healthcare to get traction up only 0.51% and down almost 5% YTD. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.